Article
Comparison of the Amyloid Plaque Proteome in Down Syndrome, Early-Onset Alzheimer’s Disease and Late-Onset Alzheimer’s Disease
2024-07-15
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold> Down syndrome (DS) is strongly associated with Alzheimer’s disease (AD), attributable to <italic>APP</italic> overexpression. DS exhibits Amyloid-β (Aβ) and Tau pathology similar to early-onset AD (EOAD) and late-onset AD (LOAD). The study aimed to evaluate the Aβ plaque proteome of DS, EOAD and LOAD.<bold>Methods</bold> Using unbiased localized proteomics, we an...
Topics
Open a Topic to create a Post that cites this publication.
- Advanced Proteomics Techniques and Applications
- Alzheimer's disease research and treatments
- Chronic Disease Management Strategies
- Dementia and Cognitive Impairment Research
- Down syndrome and intellectual disability research
- Genomics and Rare Diseases
- Metabolomics and Mass Spectrometry Studies
- Ubiquitin and proteasome pathways
Identifiers and source
- Literature Corpus work
- 8fe5d635-e7de-5899-96e3-688413b8cc65
- DOI
- 10.21203/rs.3.rs-4469045/v1
